Stock Market

InvestorPlace published an article last December about the seven hottest biotech stocks to own in 2023 and beyond. One of the seven was the SPDR S&P Biotech ETF (NYSEARCA:XBI). XBI tracks the performance of the S&P Biotechnology Select Industry Index which represents the biotechnology sub-sector of the S&P Total Market Index. XBI currently has 133
In 2024, UBS expects disinflation and rising unemployment to impact economic output, prompting the Federal Open Market Committee to implement proactive rate cuts. The FEderal Open Market Committee designed the initial cut to prevent the nominal funds rate from becoming overly restrictive amid falling inflation, with subsequent cuts later in the year to counteract economic
Initially concentrated on defense and intelligence, Palantir Technologies (NYSE:PLTR) has broadened its clientele to the healthcare, energy, and finance sectors. Noteworthy profitability and advancements in AI analytics make PLTR stock an appealing choice for investors. Despite the cooling of ‘AI mania,’ Palantir Technologies continues to hold firm, with shares not far below their 52-week highs.
Alphabet (NASDAQ:GOOGL,NASDAQ:GOOG) stock continues to be affected by the U.S. Department of Justice civil suit filed back in January, alleging that the company engaged in monopolistic and anti-competitive actions in order to maintain its dominant position in search and digital advertising markets. The trial, which started in September, is still unfolding. However, in recent days,
Many an investor grows tired of hearing about gains in the so called Magnificent Seven stocks. The market’s growth this year has been dominated by the mega-cap tech stocks. The 2023 main players are Alphabet (NASDAQ:GOOG/NASDAQ:GOOGL), Amazon (NASDAQ:AMZN), Apple (NASDAQ:AAPL), Nvidia (NASDAQ:NVDA), Meta Platforms (NASDAQ:META), Microsoft (NASDAQ:MSFT) and Tesla (NASDAQ:TSLA). The concentrated gains in a
Meta Platforms (NASDAQ:META) has a number of threats to contend with, including regulatory resistance from the European Data Protection Board. Yet, the biggest threat of all might come from a famous electric vehicle (EV) manufacturing mogul. Overall, I still like the growth prospects for META stock, but investors should consider Meta Platforms’ challenges. I must admit, Meta Platforms
S&P Global Market Intelligence recently stated that activists launched 850 investor activism campaigns in the first half of 2023. Despite the recent backlash against ESG (environment, social, and corporate governance) investing, 86% of the activist investor stocks targeted by campaigns had an ESG component.  Breaking down the numbers in H1 2023, corporate governance issues accounted
Apple (NASDAQ:AAPL) is a colossus and a member of the much-touted “Magnificent Seven” group of technology companies. So, AAPL stock deserves at least a “B” grade and most investors should feel fine holding some shares. Apple can’t execute perfectly in all areas and the company has to face challenges just like every other business does. Apple has a